Endpoints News
Apple’s latest move into health monitoring Read in browser
Endpoints News
Thursday, 11 September 2025
Thank you for reading, dupa dupackia!
basic
UPGRADE
Health Tech Day 2025
Health tech is attracting fresh capital and renewed attention — from wearable tech to EMRs, momentum is building. Join industry leaders online in the morning for everyone and in person that evening for live-only content and a reception at NYC’s Book Club Bar. Choose your pass and join the conversation.
Hypertension notification
Apple is planning to launch a high blood pressure feature on its newest watch.
The feature, which uses 30-day background data collected by the watch to identify patterns, is currently waiting for FDA clearance, but Apple expects it to be available in September. The company anticipates finding 1 million people with undiagnosed hypertension in the first year of the feature, Sumbul Desai, vice president of health at Apple said during the event.
It’s a big advancement wearable makers have been wanting to make for years. Companies like Samsung have been racing Apple to pull this off. Being able to tell someone their blood pressure based on wrist readings — and not a blood pressure cuff — could lead to more detection, and prevent serious health issues like heart attack and stroke.
But the stakes are high to get it right.
That was apparent in July, when the FDA sent wearable maker Whoop a warning letter over its blood pressure tracker, telling the company that "providing blood pressure estimation is not a low-risk function" because an error could have significant consequences for the user. (Whoop said at the time that it planned to fight the FDA over the decision.)
I’ve been fascinated with the push wearables have been making from wellness into health. It’s been years since I tested an Apple Watch, and I’ve still not committed to a wearable yet. Features like blood pressure monitoring might start to persuade me — but I think I'm still waiting for my doctor to tell me they'd find that data useful.
- Lydia 

P.S. - Have you signed up for our Health Tech Day on Nov. 6 yet? You can still get tickets to our virtual event, or if you’re in NYC that day, we’d love to see you at our happy hour. A ticket gets you an open bar, snacks and a conversation with Maven CEO Kate Ryder. Get yours here.
Here’s what’s new
Exclusive: Sophont raises $9.2M to build multimodal foundation models
Sophont wants to build a foun­da­tion mod­el that can an­a­lyze all sorts of spe­cial­ized med­ical da­ta and make it open-source.
Hims expands into hormone health with men's testosterone treatment
During Hims’ second-quarter earnings call, CEO Andrew Dudum highlighted hormonal health as one of the ways in which the company plans to grow its business to $6.5 billion in revenue by 2030.
Quote of the week
"We decided to go into the medical business against Epic, believing that we could solve much more of the problem because we're much bigger than they are." 
Oracle co-founder Larry Ellison said on Tuesday's earnings call
This week in health Тech
Oracle announced Wednesday that it’s using OpenAI’s technology in its patient portal.
Noma Therapy, which provides virtual ketamine-assisted therapy, will shut down its operations by the end of this year, Behavioral Health Business reports. The Redesign Health-backed startup announced $4 million in seed funding, Endpoints first reported in April.
OpenEvidence acquired AI-powered advertising startup Amaro as part of its push to expand and draw in more doctors to use its AI search tool. Both startups are backed by Alphabet's venture arm GV. OpenEvidence raised $210 million in July.
Texas-based clinic group and insurance company Harbor Health raised $130 million in new funding that was led by General Catalyst, 8VC and Alta Partners.
Penguin Ai has raised a $31.7 million Series A for software to automate and streamline workflows for insurers and providers. Founder and CEO Fawad Butt previously worked as the chief data officer at UnitedHealth Group and Kaiser Permanente.
Optain Health raised a $26 million Series A to use AI and robotic cameras to detect eye diseases.
John Carroll
Editor & Founder
Arsalan Arif
Publisher & Founder
Igor Yavych
Architect & Founder
Valentin Manov
Creative Director
Ryan McRae
Chief Revenue Officer
Amanda Florez
Chief of Staff
Drew Armstrong
Executive Editor
Liam Chua
Chief Technical Officer
Jaimy Lee
Deputy Editor
Lydia R. Pflanzer
Deputy Editor
Zachary Brennan
Senior Editor
Max Gelman
Senior Editor
Julie O'Meara
Executive Director, Brand Partnerships